Geoffrey M. Parker Better Therapeutics, Inc. (BTTX) insider trading activity

Geoffrey M. Parker is of Better Therapeutics, Inc.. Currently has a direct ownership of 1.03 Million shares of BTTX, which is worth approximately $0. The most recent transaction as insider was on Dec 18, 2023, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.03M

0% 3M change

0.36% 12M change

Total Value Held $0

Geoffrey M. Parker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2023	BUY Grant, award, or other acquisition	-	3,750 Added 0.36%	1,031,805 Common Stock
Jul 27 2023	BUY Open market or private purchase	$500,068 $0.73 p/Share	685,025 Added 39.99%	1,028,055 Common Stock
Apr 10 2023	BUY Open market or private purchase	$248,484 $0.82 p/Share	303,030 Added 46.9%	343,030 Common Stock
Jun 13 2022	BUY Open market or private purchase	$36,250 $1.45 p/Share	25,000 Added 38.46%	40,000 Common Stock
Mar 29 2022	BUY Open market or private purchase	$32,250 $2.15 p/Share	15,000 Added 50.0%	15,000 Common Stock

Also insider at

TCDA

Tricida, Inc. Healthcare

COO, CFO and EVP

CCXI

ChemoCentryx, Inc.

Director

PRGO

PERRIGO Co plc Healthcare

Director

ALLO

Allogene Therapeutics, Inc. Healthcare

CHIEF FINANCIAL OFFICER

GMP